Your funeral buddy. They can have the best data in the world but if they run out of cash they will fold. Genentech can buy the drug from the receivers. Everybody wins. Except JG and except the retails but Big Pharma wins what a surprise.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
Add to My Watchlist
What is My Watchlist?